Procainamide Hydrochloride
PROCAINAMIDE HYDROCHLORIDE
61 matching records for Procainamide.
PROCAINAMIDE HYDROCHLORIDE
PROCAINAMIDE HYDROCHLORIDE
PROCAINAMIDE HYDROCHLORIDE
PROCAINAMIDE HYDROCHLORIDE
PROCAINAMIDE HYDROCHLORIDE
PROCAINAMIDE HYDROCHLORIDE
PROCAINAMIDE HYDROCHLORIDE
PROCAINAMIDE HYDROCHLORIDE
PROCAINAMIDE HYDROCHLORIDE
PROCAINAMIDE HCI
PROCAINAMIDE HYDROCHLORIDE
PROCAINAMIDE HYDROCHLORIDE
PROCAINAMIDE HYDROCHLORIDE
Procainamide Hydrochloride
Procainamide Hydrochloride
Procainamide Hydrochloride
Procainamide Hydrochloride
PROCAINAMIDE HCI
PROCAINAMIDE HYDROCHLORIDE
Procainamide Hydrochloride
Procainamide Hydrochloride
Procainamide Hydrochloride
Procainamide Hydrochloride
Procainamide Hydrochloride
PROCAINAMIDE HYDROCHLORIDE
Procainamide Hydrochloride
Procainamide Hydrochloride
Procainamide Hydrochloride
procainamide hydrochloride
PROCAINAMIDE HYDROCHLORIDE
PROCAINAMIDE HCI
procainamide hydrochloride
PROCAINAMIDE HYDROCHLORIDE
Procainamide Hydrochloride
Procainamide Hydrochloride
20260708
20260619
20251202
20251028
20250217
20241218
20240723
20240219
20231121
20230424
20220113
20211122
20210201
20190731
20180813
20180406
20180301
2025-10-01
2025-08-31
15 mapped labels
A collection of reagents and other associated materials intended to be used for the quantitative measurement and therapeutic monitoring of the cardiovascular drug procainamide in a clinical specimen, using an enzyme immunoassay (EIA) method.
A collection of reagents and other associated materials intended to be used for the quantitative detection of N-acetyl procainamide (NAPA) in a clinical specimen, using a nephelometry/turbidimetry method.
A collection of reagents and other associated materials intended to be used for the quantitative measurement and therapeutic monitoring of the cardiovascular drug procainamide in a clinical specimen, using a nephelometry/turbidimetry method.
A collection of reagents and other associated materials intended to be used for the quantitative measurement of N-acetyl procainamide (NAPA) in a clinical specimen, using a fluorescent immunoassay method.
A material which is used to establish known points of reference for an assay intended to be used for the quantitative measurement of N-acetyl procainamide (NAPA) in a clinical specimen.
A material which is used to establish known points of reference for an assay intended to be used for the quantitative measurement and therapeutic monitoring of the cardiovascular drug procainamide in a clinical specimen.